In a filing, Supernus Pharmaceuticals Inc revealed its SVP, Chief Tech. Ops. Officer Mottola Frank unloaded Company’s shares for reported $0.23 million on Sep 12 ’25. In the deal valued at $45.87 per share,5,000 shares were sold. As a result of this transaction, Mottola Frank now holds 15,496 shares worth roughly $0.68 million.
Then, FRANK MOTTOLA bought 5,000 shares, generating $229,338 in total proceeds.
Before that, Khattar Jack A. sold 6,322 shares. Supernus Pharmaceuticals Inc shares valued at $292,645 were divested by the President, CEO at a price of $46.29 per share. As a result of the transaction, Khattar Jack A. now holds 1,111,983 shares, worth roughly $48.92 million.
Cantor Fitzgerald upgraded its Supernus Pharmaceuticals Inc [SUPN] rating to an Overweight from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who decreased its forecast for the stock in mid February from “an Overweight” to “a Neutral”. Cantor Fitzgerald began covering SUPN with “an Overweight” recommendation on January 06, 2025. Piper Sandler revised its rating on September 11, 2024. It rated SUPN as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of SUPN
On Monday, Supernus Pharmaceuticals Inc [NASDAQ:SUPN] saw its stock fall -3.23% to $43.99. Over the last five days, the stock has lost -3.99%. Supernus Pharmaceuticals Inc shares have risen nearly 41.54% since the year began. Nevertheless, the stocks have risen 21.65% over the past one year.
How much short interest is there in Supernus Pharmaceuticals Inc?
A steep rise in short interest was recorded in Supernus Pharmaceuticals Inc stocks on 2025-08-29, dropping by -0.28 million shares to a total of 4.8 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 5.08 million shares. There was a decline of -5.83%, which implies that there is a negative sentiment for the stock.
